BOTOTLSJU
CLVS

Board of Trustees of The Leland Stanford Junior University’s Clovis Oncology, Inc. CLVS Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,780
Closed -$354K – 22
2017
Q2 		$354K Buy
+3,780
New +$231K 0.04% 11
2014
Q2 		– Sell
-25,995
Closed -$1.8M – 48
2014
Q1 		$1.8M Buy
+25,995
New +$1.91M 0.68% 40

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's CLVS Position: Q3 2017 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 3,780 shares — an estimated $354K sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in CLVS in Q1 2014 and held it in 2 quarters. The position peaked at $1.8M in Q1 2014. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 3,780 Clovis Oncology, Inc. shares in Q3 2017, an estimated $354K.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 2 quarters.
  • Board of Trustees of The Leland Stanford Junior University's Clovis Oncology, Inc. position peaked at $1.8M in Q1 2014.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q3 2017, filed 13 Nov 2017.